229 related articles for article (PubMed ID: 23954892)
1. Anti-β2GPI antibodies stimulate endothelial cell microparticle release via a nonmuscle myosin II motor protein-dependent pathway.
Betapudi V; Lominadze G; Hsi L; Willard B; Wu M; McCrae KR
Blood; 2013 Nov; 122(23):3808-17. PubMed ID: 23954892
[TBL] [Abstract][Full Text] [Related]
2. TLR4 is involved in the pathogenic effects observed in a murine model of antiphospholipid syndrome.
Xie H; Kong X; Zhou H; Xie Y; Sheng L; Wang T; Xia L; Yan J
Clin Immunol; 2015 Oct; 160(2):198-210. PubMed ID: 26065621
[TBL] [Abstract][Full Text] [Related]
3. β2-Glycoprotein-I based peptide regulate endothelial-cells tissue-factor expression via negative regulation of pGSK3β expression and reduces experimental-antiphospholipid-syndrome.
Blank M; Baraam L; Eisenstein M; Fridkin M; Dardik R; Heldman Y; Katchalski-Katzir E; Shoenfeld Y
J Autoimmun; 2011 Aug; 37(1):8-17. PubMed ID: 21524885
[TBL] [Abstract][Full Text] [Related]
4. β2-glycoprotein I, lipopolysaccharide and endothelial TLR4: three players in the two hit theory for anti-phospholipid-mediated thrombosis.
Raschi E; Chighizola CB; Grossi C; Ronda N; Gatti R; Meroni PL; Borghi MO
J Autoimmun; 2014 Dec; 55():42-50. PubMed ID: 24685231
[TBL] [Abstract][Full Text] [Related]
5. Bad (or good) things come in small packages.
Rauova L; Cines DB
Blood; 2013 Nov; 122(23):3707-8. PubMed ID: 24288408
[TBL] [Abstract][Full Text] [Related]
6. A novel pathway of cellular activation mediated by antiphospholipid antibody-induced extracellular vesicles.
Wu M; Barnard J; Kundu S; McCrae KR
J Thromb Haemost; 2015 Oct; 13(10):1928-40. PubMed ID: 26264622
[TBL] [Abstract][Full Text] [Related]
7. Antiphospholipid antibodies promote leukocyte-endothelial cell adhesion and thrombosis in mice by antagonizing eNOS via β2GPI and apoER2.
Ramesh S; Morrell CN; Tarango C; Thomas GD; Yuhanna IS; Girardi G; Herz J; Urbanus RT; de Groot PG; Thorpe PE; Salmon JE; Shaul PW; Mineo C
J Clin Invest; 2011 Jan; 121(1):120-31. PubMed ID: 21123944
[TBL] [Abstract][Full Text] [Related]
8. Circulating microparticles in patients with antiphospholipid antibodies: characterization and associations.
Chaturvedi S; Cockrell E; Espinola R; Hsi L; Fulton S; Khan M; Li L; Fonseca F; Kundu S; McCrae KR
Thromb Res; 2015 Jan; 135(1):102-8. PubMed ID: 25467081
[TBL] [Abstract][Full Text] [Related]
9. Platelet and endothelial activation in catastrophic and quiescent antiphospholipid syndrome.
Bontadi A; Ruffatti A; Falcinelli E; Giannini S; Marturano A; Tonello M; Hoxha A; Pengo V; Punzi L; Momi S; Gresele P
Thromb Haemost; 2013 May; 109(5):901-8. PubMed ID: 23572134
[TBL] [Abstract][Full Text] [Related]
10. Role of anti-beta2 glycoprotein I antibodies in antiphospholipid syndrome: in vitro and in vivo studies.
Meroni PL; Ronda N; De Angelis V; Grossi C; Raschi E; Borghi MO
Clin Rev Allergy Immunol; 2007 Feb; 32(1):67-74. PubMed ID: 17426362
[TBL] [Abstract][Full Text] [Related]
11. The role of thrombospondin-1 in the pathogenesis of antiphospholipid syndrome.
Patsouras M; Tsiki E; Karagianni P; Vlachoyiannopoulos PG
J Autoimmun; 2020 Dec; 115():102527. PubMed ID: 32709480
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of anti-domain 1 β2-glycoprotein I antibodies in antiphospholipid syndrome.
Iwaniec T; Kaczor MP; Celińska-Löwenhoff M; Polański S; Musiał J
Thromb Res; 2017 May; 153():90-94. PubMed ID: 28363116
[TBL] [Abstract][Full Text] [Related]
13. Soluble analog of ApoER2 targeting beta2-glycoprotein I in immune complexes counteracts hypertension in lupus-prone mice with spontaneous antiphospholipid syndrome.
Kolyada A; Ke Q; Karageorgos I; Mahlawat P; Barrios DA; Kang PM; Beglova N
J Thromb Haemost; 2016 Jun; 14(6):1298-307. PubMed ID: 26990752
[TBL] [Abstract][Full Text] [Related]
14. Platelet-derived microparticles stimulated by anti-β
Di L; Zha C; Liu Y
Platelets; 2023 Dec; 34(1):2156492. PubMed ID: 36550078
[TBL] [Abstract][Full Text] [Related]
15. A peptide that mimics the Vth region of beta-2-glycoprotein I reverses antiphospholipid-mediated thrombosis in mice.
Ostertag MV; Liu X; Henderson V; Pierangeli SS
Lupus; 2006; 15(6):358-65. PubMed ID: 16830882
[TBL] [Abstract][Full Text] [Related]
16. Probing antiphospholipid-mediated thrombosis: the interplay between anticardiolipin antibodies and endothelial cells.
Pierangeli SS; Harris EN
Lupus; 2003; 12(7):539-45. PubMed ID: 12892395
[TBL] [Abstract][Full Text] [Related]
17. Nonmuscle myosin IIA with a GFP fused to the N-terminus of the regulatory light chain is regulated normally.
Kengyel A; Wolf WA; Chisholm RL; Sellers JR
J Muscle Res Cell Motil; 2010 Sep; 31(3):163-70. PubMed ID: 20711642
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of anti-phospholipid antibody formation and action.
de Groot PG
Thromb Res; 2011 Feb; 127 Suppl 3():S40-2. PubMed ID: 21262437
[TBL] [Abstract][Full Text] [Related]
19. Annexin A2 mediates endothelial cell activation by antiphospholipid/anti-beta2 glycoprotein I antibodies.
Zhang J; McCrae KR
Blood; 2005 Mar; 105(5):1964-9. PubMed ID: 15471954
[TBL] [Abstract][Full Text] [Related]
20. Complement activity and complement regulatory gene mutations are associated with thrombosis in APS and CAPS.
Chaturvedi S; Braunstein EM; Yuan X; Yu J; Alexander A; Chen H; Gavriilaki E; Alluri R; Streiff MB; Petri M; Crowther MA; McCrae KR; Brodsky RA
Blood; 2020 Jan; 135(4):239-251. PubMed ID: 31812994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
